Jotec内分支支架在复杂EVAR中的早期结果
单中心回顾2018-2020年18例使用Jotec定制内分支支架行复杂EVAR的患者,技术成功率100%,68根目标血管均成功置入桥接支架,无30天死亡和主要并发症,中位随访12个月无I/III型内漏,早期再干预率低。
要点
- 内分支设计适用于靶血管走行不佳、肾下主动脉成角大或入路不良、主动脉管腔窄等解剖条件。
- 18例患者中位随访12个月,动脉瘤均隔绝、目标血管通畅、无I/III型内漏。
- 早期再干预2例,分别为疑Ib型内漏和肾桥接支架内狭窄,无30天死亡。
核心结论
- Jotec定制向下内分支支架行复杂EVAR早期结果满意,再干预率低。
- 该技术有望成为复杂主动脉腔内治疗的有用补充,但需长期随访数据。
研究设计与样本
- 单中心回顾性研究,纳入2018-2020年使用Jotec定制内分支支架行复杂EVAR的18例患者。
- 研究期间共110例患者接受分支/开窗支架治疗,其中18例使用定制内分支支架。
主要发现
- 技术成功率100%,68根目标血管均成功置入桥接支架。
- 无30天死亡和主要并发症,1例早期再干预(疑Ib型内漏),1例晚期再干预(肾桥接支架内狭窄)。
- 中位随访12个月(范围1-26个月),动脉瘤均隔绝、目标血管通畅、无I/III型内漏。
- 中位造影剂用量120 mL(范围48-200 mL),中位透视时间66分钟(范围35-136分钟),中位剂量面积乘积17,832 dGy∙cm2(范围8260-55,070 dGycm2)。
- 选择内分支的原因包括靶血管走行不适于开窗(n=15)、肾下主动脉成角大和/或髂入路不良(n=11)、主动脉管腔窄(n=14)、减少主动脉覆盖(n=14),以及治疗短主体EVAR失败后Ia型内漏(n=5)。
临床怎么用
- 对于靶血管走行不佳、肾下主动脉成角大或入路不良、主动脉管腔窄等复杂解剖,可考虑使用Jotec内分支支架。
- 该技术也可用于短主体EVAR失败后Ia型内漏的补救治疗。
局限性
- 单中心、小样本(18例)回顾性研究。
- 随访时间短,中位仅12个月,缺乏长期结果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Complex aortic endografts have evolved to include inner branches to overcome specific challenges with existing technologies. We have reported the early outcomes of endovascular aortic aneurysm repair (EVAR) using a Jotec inner branched endograft (iBEVAR). METHODS: All patients who had undergone complex EVARs using extra-design engineering iBEVAR (Jotec GmbH, Hechingen, Germany) from 2018 to 2020 at a single center were reviewed. The patient demographics, cardiovascular risk factors, anatomic features of the aneurysms, and target vessels were recorded. The reasons for using inner branches instead of fenestrated and standard branched endografts and the procedural details, outcomes, and reintervention during follow-up were examined. RESULTS: A total of 110 patients were treated with branched and fenestrated endografts during the study period, of whom 18 patients had had a patient-specific custom-made iBEVAR endograft with downward inner branches. The technical success rate was 100%. A total of 68 target vessels were cannulated, and bridging stent-grafts were placed successfully in all. The reasons for choosing the iBEVAR design included unfavorable target vessel trajectory for fenestrated repair (n = 15), excessive infrarenal aortic angulation and/or adverse iliac access vessels for fenestrated repair (n = 11), the presence of a narrow aortic lumen (n = 14), and/or to reduce aortic coverage compared with that with standard outer branched repair (n = 14). We also used iBEVAR to treat type Ia endoleaks after failed EVAR with a short main body (n = 5). The median contrast volume used was 120 mL (range, 48-200 mL), with a median fluoroscopy screening time of 66 minutes (range, 35-136 minutes) and a median dose-area product of 17,832 dGy∙cm2 (range, 8260-55,070 dGycm2). No 30-day mortality and no major complications occurred. One early intervention was required for a suspected type Ib endoleak from an iliac limb and one late intervention for in-stent stenosis in a renal bridging stent-graft. One patient had died of non-aortic-related causes at 3 months. All other patients continued with follow-up with their aneurysms excluded, patent target vessels, and no type I or III endoleak identified at a median follow-up of 12 months (range, 1-26 months). CONCLUSIONS: The use of Jotec extra-design engineering endografts incorporating downward inner branches resulted in satisfactory early outcomes with a low reintervention rate. The technology has the potential to be a useful addition to our armamentarium for treating complex aortic endografts; however, long-term outcomes data are needed.
引用
- Abisi S, Zymvragoudakis V, Gkoutzios P, et al. Early outcomes of Jotec inner-branched endografts in complex endovascular aortic aneurysm repair. J Vasc Surg. 2021. PMID: 33647435. doi:10.1016/j.jvs.2021.01.067
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。